DYT-40, a novel synthetic 2-styryl-5-nitroimidazole derivative, blocks malignant glioblastoma growth and invasion by inhibiting AEG-1 and NF-κB signaling pathways

Scientific Reports

Volumn 6, Issue , 2016, Pages

  Zou, Meijuan ^a,b   Duan, Yongtao ^b   Wang, Pengfei ^b   Gao, Rui ^a   Chen, Xuguan ^a   Ou, Yingwei ^a   Liang, Mingxing ^a   Wang, Zhongchang ^b   Yuan, Yi ^a   Wang, Li ^c   Zhu, Hailiang ^a,b  

^a NANJING MEDICAL UNIVERSITY   (China)

^b NANJING UNIVERSITY   (China)

^c THE FIRST AFFILIATED HOSPITAL OF NANJING MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

2-STYRYL-5-NITROIMIDAZOLE; ANTINEOPLASTIC AGENT; CELL ADHESION MOLECULE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MTDH PROTEIN, HUMAN; NITROIMIDAZOLE DERIVATIVE;

ANIMAL; CYTOCHEMISTRY; DISEASE MODEL; GLIOBLASTOMA; HUMAN; IMMUNOHISTOCHEMISTRY; METABOLISM; MICROSCOPY; PATHOLOGY; RAT; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; TUMOR CELL LINE;

ANIMALS; ANTINEOPLASTIC AGENTS; CELL ADHESION MOLECULES; CELL LINE, TUMOR; DISEASE MODELS, ANIMAL; GLIOBLASTOMA; HISTOCYTOCHEMISTRY; HUMANS; IMMUNOHISTOCHEMISTRY; MICROSCOPY; NF-KAPPA B; NITROIMIDAZOLES; RATS; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

EID: 84973345477     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep27331     Document Type: Article

References (53)

1. Stupp, R. et al. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 352, 987-996, doi: 10.1056/NEJMoa043330 (2005).
2. Cavenee, W. K. Accumulation of genetic defects during astrocytoma progression. Cancer 70, 1788-1793 (1992).
3. Holland, E. C. Gliomagenesis: genetic alterations and mouse models. Nat Rev Genet 2, 120-129, doi: 10.1038/35052535 (2001).
4. Emdad, L. et al. Astrocyte elevated gene-1: A novel target for human glioma therapy. Mol Cancer Ther 9, 79-88, doi: 10.1158/1535-7163.MCT-09-0752 (2010).
5. Su, Z. Z. et al. Identification and cloning of human astrocyte genes displaying elevated expression after infection with HIV-1 or exposure to HIV-1 envelope glycoprotein by rapid subtraction hybridization, RaSH. Oncogene 21, 3592-3602, doi: 10.1038/sj. onc.1205445 (2002).
6. Kang, D. C. et al. Cloning and characterization of HIV-1-inducible astrocyte elevated gene-1, AEG-1. Gene 353, 8-15, doi: 10.1016/j. gene.2005.04.006 (2005).
7. Lee, S. G., Su, Z. Z., Emdad, L., Sarkar, D. & Fisher, P. B. Astrocyte elevated gene-1 (AEG-1) is A target gene of oncogenic Ha-ras requiring phosphatidylinositol 3-kinase and c-Myc. Proc Natl Acad Sci. USA 103, 17390-17395, doi: 10.1073/pnas.0608386103 (2006).
8. Emdad, L. et al. Activation of the nuclear factor kappaB pathway by astrocyte elevated gene-1: implications for tumor progression and metastasis. Cancer Res. 66, 1509-1516, doi: 10.1158/0008-5472.CAN-05-3029 (2006).
9. Kikuno, N. et al. Knockdown of astrocyte-elevated gene-1 inhibits prostate cancer progression through upregulation of FOXO3a activity. Oncogene 26, 7647-7655, doi: 10.1038/sj.onc.1210572 (2007).
10. Yoo, B. K. et al. Astrocyte elevated gene-1 regulates hepatocellular carcinoma development and progression. J Clin Invest 119, 465-477, doi: 10.1172/JCI36460 (2009).
11. Lee, S. G. et al. Astrocyte elevated gene-1 contributes to the pathogenesis of neuroblastoma. Oncogene 28, 2476-2484, doi: 10.1038/onc.2009.93 (2009).
12. Emdad, L. et al. Astrocyte elevated gene-1: recent insights into A novel gene involved in tumor progression, metastasis and neurodegeneration. Pharmacol Ther 114, 155-170, doi: 10.1016/j.pharmthera.2007.01.010 (2007).
13. He, W. et al. Astrocyte elevated gene-1(AEG-1) induces epithelial-mesenchymal transition in lung cancer through activating Wnt/beta-catenin signaling. BMC Cancer 15, 107, doi: 10.1186/s12885-015-1124-1 (2015).
14. Seger, R. & Krebs, E. G. The MAPK signaling cascade. FASEB J 9, 726-735 (1995).
15. Kauffmann-Zeh, A. et al. Suppression of c-Myc-induced apoptosis by Ras signalling through PI(3)K and PKB. Nature 385, 544-548, doi: 10.1038/385544a0 (1997).
16. Bader, A. G., Kang, S., Zhao, L. & Vogt, P. K. Oncogenic PI3K deregulates transcription and translation. Nat Rev Cancer 5, 921-929, doi: 10.1038/nrc1753 (2005).
17. Chen, C. & Sytkowski, A. J. Erythropoietin activates two distinct signaling pathways required for the initiation and the elongation of c-myc. J Biol Chem 276, 38518-38526, doi: 10.1074/jbc.M105702200 (2001).
18. Gregory, M. A., Qi, Y. & Hann, S. R. Phosphorylation by glycogen synthase kinase-3 controls c-myc proteolysis and subnuclear localization. J Biol Chem 278, 51606-51612, doi: 10.1074/jbc.M310722200 (2003).
19. Lee, S. G. et al. Astrocyte elevated gene-1 activates cell survival pathways through PI3K-Akt signaling. Oncogene 27, 1114-1121, doi: 10.1038/sj.onc.1210713 (2008).
20. Karin, M. & Greten, F. R. NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat Rev Immunol 5, 749-759, doi: 10.1038/nri1703 (2005).
21. Sarkar, D. et al. Molecular basis of nuclear factor-kappaB activation by astrocyte elevated gene-1. Cancer Res 68, 1478-1484, doi: 10.1158/0008-5472.CAN-07-6164 (2008).
22. Duan, Y. T. et al. Synthesis, biological evaluation, and molecular docking studies of novel 2-styryl-5-nitroimidazole derivatives containing 1,4-benzodioxan moiety as FAK inhibitors with anticancer activity. Bioorg Med Chem 22, 2947-2954, doi: 10.1016/j. bmc.2014.04.005 (2014).
23. Zou, M. et al. Oroxylin A induces autophagy in human malignant glioma cells via the mTOR-STAT3-Notch signaling pathway. Mol Carcinog, doi: 10.1002/mc.22212 (2014).
24. Liu, K. et al. Ursolic acid inhibits epithelial-mesenchymal transition by suppressing the expression of astrocyte-elevated gene-1 in human nonsmall cell lung cancer A549 cells. Anticancer Drugs 24, 494-503, doi: 10.1097/CAD.0b013e328360093b (2013).
25. Zou, M. et al. Beclin 1-mediated autophagy in hepatocellular carcinoma cells: implication in anticancer efficiency of oroxylin A via inhibition of mTOR signaling. Cell Signal 24, 1722-1732, doi: 10.1016/j.cellsig.2012.04.009 (2012).
26. Zhao, J. et al. Inhibition of alpha(4) integrin mediated adhesion was involved in the reduction of B16-F10 melanoma cells lung colonization in C57BL/6 mice treated with gambogic acid. Eur J Pharmacol 589, 127-131, doi: 10.1016/j.ejphar.2008.04.063 (2008).
27. Chen, P. N. et al. Silibinin inhibits invasion of oral cancer cells by suppressing the MAPK pathway. J Dent Res 85, 220-225 (2006).
28. Liu, K. et al. AEG-1 3′-untranslated region functions as A ceRNA in inducing epithelial-mesenchymal transition of human nonsmall cell lung cancer by regulating miR-30a activity. Eur J Cell Biol 94, 22-31, doi: 10.1016/j.ejcb.2014.10.006 (2014).
29. Liu, P. et al. Silver nanoparticles: A novel radiation sensitizer for glioma? Nanoscale 5, 11829-11836, doi: 10.1039/c3nr01351k (2013).
30. Brockmann, M. A. et al. Inhibition of intracerebral glioblastoma growth by local treatment with the scatter factor/hepatocyte growth factor-antagonist NK4. Clin Cancer Res 9, 4578-4585 (2003).
31. Choi, J. H. et al. Suppression of PMA-induced tumor cell invasion and metastasis by aqueous extract isolated from Prunella vulgaris via the inhibition of NF-kappaB-dependent MMP-9 expression. Food Chem Toxicol 48, 564-571, doi: 10.1016/j.fct.2009.11.033 (2010).
32. Karin, M. Nuclear factor-kappaB in cancer development and progression. Nature 441, 431-436, doi: 10.1038/nature04870 (2006).
33. Karin, M. & Ben-Neriah, Y. Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity. Annu Rev Immunol 18, 621-663, doi: 10.1146/annurev.immunol.18.1.621 (2000).
34. Ducut Sigala, J. L. et al. Activation of transcription factor NF-kappaB requires ELKS, an IkappaB kinase regulatory subunit. Science 304, 1963-1967, doi: 10.1126/science.1098387 (2004).
35. Ying, Z., Li, J. & Li, M. Astrocyte elevated gene 1: biological functions and molecular mechanism in cancer and beyond. Cell Biosci 1, 36, doi: 10.1186/2045-3701-1-36 (2011).
36. Yu, C. et al. Overexpression of astrocyte elevated gene-1 (AEG-1) is associated with esophageal squamous cell carcinoma (ESCC) progression and pathogenesis. Carcinogenesis 30, 894-901, doi: 10.1093/carcin/bgp064 (2009).
37. Zou, M. et al. AEG-1/MTDH-activated autophagy enhances human malignant glioma susceptibility to TGF-beta1-triggered epithelial-mesenchymal transition. Oncotarget, doi: 10.18632/oncotarget.7536 (2016).
38. Yoo, B. K. et al. Increased RNA-induced silencing complex (RISC) activity contributes to hepatocellular carcinoma. Hepatology 53, 1538-1548, doi: 10.1002/hep.24216 (2011).
39. Bhutia, S. K. et al. Astrocyte elevated gene-1 induces protective autophagy. Proc Natl Acad Sci. USA 107, 22243-22248, doi: 10.1073/pnas.1009479107 (2010).
40. Gatti, L. et al. Apoptosis and growth arrest induced by platinum compounds in U2-OS cells reflect A specific DNA damage recognition associated with A different p53-mediated response. Cell Death Differ 9, 1352-1359, doi: 10.1038/sj.cdd.4401109 (2002).
41. Lawen, A. Apoptosis-an introduction. Bioessays 25, 888-896, doi: 10.1002/bies.10329 (2003).
42. Kroemer, G. Mitochondrial control of apoptosis: an introduction. Biochem Biophys Res Commun 304, 433-435 (2003).
43. Satchell, P. G., Gutmann, J. L. & Witherspoon, D. E. Apoptosis: an introduction for the endodontist. Int Endod J 36, 237-245 (2003).
44. Roos, W. P. & Kaina, B. DNA damage-induced cell death: from specific DNA lesions to the DNA damage response and apoptosis. Cancer Lett 332, 237-248, doi: 10.1016/j.canlet.2012.01.007 (2012).
45. Antonsson, B. & Martinou, J. C. The Bcl-2 protein family. Exp Cell Res 256, 50-57, doi: 10.1006/excr.2000.4839 (2000).
46. Yang, H. L., Dong, Y. B., Elliott, M. J., Liu, T. J. & McMasters, K. M. Caspase activation and changes in Bcl-2 family member protein expression associated with E2F-1-mediated apoptosis in human esophageal cancer cells. Clin Cancer Res. 6, 1579-1589 (2000).
47. Wang, B. et al. Deficiency of caspase 3 in tumor xenograft impairs therapeutic effect of measles virus Edmoston strain. Oncotarget 6, 16019-16030, doi: 10.18632/oncotarget.3496 (2015).
48. Henshall, D. C. et al. Alterations in bcl-2 and caspase gene family protein expression in human temporal lobe epilepsy. Neurology 55, 250-257 (2000).
49. Christofori, G. New signals from the invasive front. Nature 441, 444-450, doi: 10.1038/nature04872 (2006).
50. Liang, X. EMT: new signals from the invasive front. Oral Oncol 47, 686-687, doi: 10.1016/j.oraloncology.2011.04.016 (2011).
51. Lan, L. et al. Epithelial-mesenchymal transition triggers cancer stem cell generation in human thyroid cancer cells. Int J Oncol 43, 113-120, doi: 10.3892/ijo.2013.1913 (2013).
52. Spano, D. & Zollo, M. Tumor microenvironment: A main actor in the metastasis process. Clin Exp Metastasis 29, 381-395, doi: 10.1007/s10585-012-9457-5 (2012).
53. Qiang, L. et al. Inhibition of glioblastoma growth and angiogenesis by gambogic acid: an in vitro and in vivo study. Biochem Pharmacol 75, 1083-1092, doi: 10.1016/j.bcp.2007.10.033 (2008).